Entrada Therapeutics (TRDA) Revenue (2023 - 2026)
Entrada Therapeutics (TRDA) posted quarterly Revenue of $875000.0 for Q1 2026, down 95.74% year-over-year from $20.6 million in Q1 2025, and down 32.64% quarter-over-quarter from $1.3 million in Q4 2025.
Entrada Therapeutics (TRDA) Revenue (2023 - 2026) Analysis & Trends
Entrada Therapeutics' Revenue history runs 4 years deep, the most recent figure standing at $875000.0 for Q1 2026.
- In Q1 2026, Revenue fell 95.74% year-over-year to $875000.0; the TTM figure through Mar 2026 stood at $5.7 million (down 96.67% YoY), while the FY2025 annual figure was $25.4 million, down 87.94% from the prior year.
- Revenue for Q1 2026 stood at $875000.0, down from $1.3 million in the prior quarter.
- The five-year high for Revenue was $94.7 million in Q2 2024, with the low at $875000.0 in Q1 2026.
- The 4-year median for Revenue is $20.6 million (2025), against an average of $28.2 million.
- The sharpest annual moves came in 2024 and 2025: Revenue soared 421.16% in 2024, then sank 97.94% in 2025.
- Entrada Therapeutics' Revenue stood at $41.8 million in 2023, then slipped by 10.63% to $37.4 million in 2024, then slumped by 96.53% to $1.3 million in 2025, then sank by 32.64% to $875000.0 in 2026.
- Business Quant data shows TRDA's Revenue at $875000.0 in Q1 2026, $1.3 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Entrada Therapeutics | 290.47 Mn | 290.47 Mn | - | 898,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 898,000.00 |
| Mar 31, 2026 | 875,000.00 |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.61 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 20.56 Mn |
| Dec 31, 2024 | 37.40 Mn |
| Sep 30, 2024 | 19.57 Mn |
| Jun 30, 2024 | 94.69 Mn |
| Mar 31, 2024 | 59.12 Mn |
| Dec 31, 2023 | 41.85 Mn |
| Sep 30, 2023 | 43.74 Mn |
| Jun 30, 2023 | 18.17 Mn |
| Mar 31, 2023 | 25.26 Mn |